Barinder Kang

771 total citations
26 papers, 627 citations indexed

About

Barinder Kang is a scholar working on Molecular Biology, Genetics and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Barinder Kang has authored 26 papers receiving a total of 627 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 9 papers in Genetics and 8 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Barinder Kang's work include Hemoglobinopathies and Related Disorders (7 papers), Cancer Genomics and Diagnostics (5 papers) and Advanced Breast Cancer Therapies (4 papers). Barinder Kang is often cited by papers focused on Hemoglobinopathies and Related Disorders (7 papers), Cancer Genomics and Diagnostics (5 papers) and Advanced Breast Cancer Therapies (4 papers). Barinder Kang collaborates with scholars based in United States and Canada. Barinder Kang's co-authors include Leonard G. Meggs, Ashwani Malhotra, Stanley K. Frencher, Alex Kessler, Venkatesh Pilla Reddy, Paul Harmatz, Patricia J. Giardina, Carole Paley, John C. Wood and Thomas D. Coates and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Diabetes.

In The Last Decade

Barinder Kang

24 papers receiving 598 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Barinder Kang United States 11 250 160 151 113 71 26 627
Jeffrey Baust United States 15 225 0.9× 74 0.5× 67 0.4× 108 1.0× 61 0.9× 25 754
Yoji Shibayama United States 13 183 0.7× 407 2.5× 212 1.4× 51 0.5× 78 1.1× 23 818
Eric Neau France 13 334 1.3× 336 2.1× 99 0.7× 188 1.7× 15 0.2× 22 830
Ayad A. Jaffa United States 17 286 1.1× 208 1.3× 62 0.4× 120 1.1× 17 0.2× 34 692
Stefano Di Giulio Italy 10 133 0.5× 63 0.4× 88 0.6× 42 0.4× 65 0.9× 20 487
Toshiyuki Ishibashi Japan 19 302 1.2× 76 0.5× 175 1.2× 255 2.3× 87 1.2× 61 1.0k
Teguh Haryo Sasongko Malaysia 15 270 1.1× 190 1.2× 54 0.4× 40 0.4× 13 0.2× 54 589
Masaki Togawa Japan 17 471 1.9× 102 0.6× 218 1.4× 237 2.1× 160 2.3× 33 1.2k
Kay Herbrig Germany 14 421 1.7× 56 0.3× 39 0.3× 185 1.6× 37 0.5× 18 809
Zhirong Yang United States 16 427 1.7× 313 2.0× 134 0.9× 94 0.8× 19 0.3× 24 904

Countries citing papers authored by Barinder Kang

Since Specialization
Citations

This map shows the geographic impact of Barinder Kang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Barinder Kang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Barinder Kang more than expected).

Fields of papers citing papers by Barinder Kang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Barinder Kang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Barinder Kang. The network helps show where Barinder Kang may publish in the future.

Co-authorship network of co-authors of Barinder Kang

This figure shows the co-authorship network connecting the top 25 collaborators of Barinder Kang. A scholar is included among the top collaborators of Barinder Kang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Barinder Kang. Barinder Kang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Heath, Elisabeth I., Neal D. Shore, Daniel J. George, et al.. (2025). Real-world treatment patterns and outcomes in advanced prostate cancer: A cohort study using the prostate cancer disease observation (PRECISION) data platform.. Journal of Clinical Oncology. 43(5_suppl). 59–59.
2.
Warner, Allison Betof, et al.. (2022). Real-world outcomes of different lines and sequences of treatment in BRAF-positive advanced melanoma patients. Melanoma Research. 33(1). 38–49. 3 indexed citations
3.
4.
Satija, Ambika, A. Simon Pickard, Raluca Ionescu‐Ittu, et al.. (2020). Management of pyrexia in metastatic melanoma patients: A real-world clinical experience survey study.. Journal of Clinical Oncology. 38(15_suppl). e22102–e22102. 2 indexed citations
5.
Peguero, Julio A., Davendra Sohal, Bert H. O’Neil, et al.. (2019). Tissue/Site-Agnostic Study of Ribociclib for Tumors With Cyclin D–CDK4/6 Pathway Genomic Alterations: A Phase II, Open-Label, Single-Arm Basket Study. JCO Precision Oncology. 3(3). 1–10. 15 indexed citations
6.
Slosberg, Eric D., Barinder Kang, Julio A. Peguero, et al.. (2018). Signature program: a platform of basket trials. Oncotarget. 9(30). 21383–21395. 32 indexed citations
7.
Peguero, Julio A., Bert H. O’Neil, Davendra Sohal, et al.. (2016). Genomic mutation profiling (GMP) and clinical outcome in patients (pts) treated with ribociclib (CDK4/6 inhibitor) in the Signature program.. Journal of Clinical Oncology. 34(15_suppl). 2528–2528. 6 indexed citations
8.
Piha‐Paul, Sarina A., James A. Knost, Petros Nikolinakos, et al.. (2015). Colorectal cancer (CRC) cohort analysis of patients treated with buparlisib in a distinctive tissue-agnostic trial model for molecularly preselected tumors.. Journal of Clinical Oncology. 33(3_suppl). 644–644. 1 indexed citations
9.
Slosberg, Eric D., Barinder Kang, J. Thaddeus Beck, et al.. (2014). The signature program, a series of tissue-agnostic, mutation-specific signal finding trials.. Journal of Clinical Oncology. 32(15_suppl). TPS2646–TPS2646. 2 indexed citations
10.
Giles, Frank, Sarina A. Piha‐Paul, Alexander I. Spira, et al.. (2014). The Signature Program, a Distinctive Tissue Agnostic Trial Model for Molecularly Pre-Selected Hematological and Solid Tumor Patients. Blood. 124(21). 4818–4818. 1 indexed citations
11.
Wood, John C., Patricia J. Giardina, Paul Harmatz, et al.. (2011). Relationship between labile plasma iron, liver iron concentration and cardiac response in a deferasirox monotherapy trial. Haematologica. 96(7). 1055–1058. 32 indexed citations
12.
Wood, John C., Barinder Kang, Alexis A. Thompson, et al.. (2010). The effect of deferasirox on cardiac iron in thalassemia major: impact of total body iron stores. Blood. 116(4). 537–543. 116 indexed citations
13.
Wood, John C., Alexis A. Thompson, Carole Paley, et al.. (2008). Deferasirox (Exjade®) Monotherapy Significantly Reduces Cardiac Iron Burden in Chronically Transfused β-Thalassemia Patients: An MRI T2* Study. Blood. 112(11). 3882–3882. 12 indexed citations
14.
Wood, John C., Alexis A. Thompson, Carole Paley, et al.. (2007). Exjade® Reduces Cardiac Iron Burden in Chronically Transfused β-Thalassemia Patients: An MRI T2* Study.. Blood. 110(11). 2781–2781. 3 indexed citations
15.
Greenberg, Peter L., et al.. (2006). Liver Iron Concentration Measurements Using MRI R2 in MDS Patients in a Deferasirox (Exjade®, ICL670) Phase II Study.. Blood. 108(11). 4846–4846. 2 indexed citations
16.
Malhotra, Ashwani, et al.. (2005). PKC? inhibits the hyperglycemia-induced apoptosis signal in adult rat ventricular myocytes. Molecular and Cellular Biochemistry. 268(1-2). 169–173. 21 indexed citations
17.
Malhotra, Ashwani, Rebecca Begley, Barinder Kang, et al.. (2005). PKC-ε-dependent survival signals in diabetic hearts. American Journal of Physiology-Heart and Circulatory Physiology. 289(4). H1343–H1350. 36 indexed citations
18.
Kang, Barinder, Stanley K. Frencher, Venkatesh Pilla Reddy, et al.. (2003). High glucose promotes mesangial cell apoptosis by oxidant-dependent mechanism. American Journal of Physiology-Renal Physiology. 284(3). F455–F466. 140 indexed citations
19.
Malhotra, Ashwani, et al.. (2001). Molecular biology of protein kinase C signaling in cardiac myocytes. Molecular and Cellular Biochemistry. 225(1-2). 97–107. 43 indexed citations
20.
Malhotra, Ashwani, et al.. (2001). Angiotensin II Promotes Glucose-Induced Activation of Cardiac Protein Kinase C Isozymes and Phosphorylation of Troponin I. Diabetes. 50(8). 1918–1926. 75 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jeffrey Baust Breakdown of academic impact, for papers by Yoji Shibayama Breakdown of academic impact, for papers by Eric Neau Breakdown of academic impact, for papers by Ayad A. Jaffa Breakdown of academic impact, for papers by Stefano Di Giulio Breakdown of academic impact, for papers by Toshiyuki Ishibashi Breakdown of academic impact, for papers by Teguh Haryo Sasongko Breakdown of academic impact, for papers by Masaki Togawa Breakdown of academic impact, for papers by Kay Herbrig Breakdown of academic impact, for papers by Zhirong Yang
Rankless by CCL
2026